HOME >> BIOLOGY >> NEWS
Researchers develop better understanding of immune response to viral infection

An appropriate response by the immune system to viral infection is absolutely critical for survival. A new research study published in the July issue of Immunity sheds light on the complex and well-orchestrated signals that are mobilized in response to infection with cytomegalovirus.

Cells infected with a virus secrete substances called interferons. Interferon serves to protect other cells from infection by "interfering" with the ability of a virus to make more of itself. Interferon-producing cells (IPCs) are a very small subset of cells in the blood that respond to viral infection by secreting large amounts of interferons and other cytokines, important chemical mediators that stimulate the immune system. It is not clear how IPCs or another interferon-secreting cell type, dendritic cells (DCs), respond to a wide spectrum of viruses. However, a protein called toll-like receptor (TLR) 9 has been implicated.

To better understand how the process is coordinated, Dr. Marco Colonna and colleagues from the Washington University School of Medicine in St. Louis examined immune responses in mice with a systemic murine cytomegalovirus (MCMV) infection. The researchers observed that MCMV causes IPCs and DCs to secrete interferons and other cytokines that activate natural killer (NK) cells that directly attack and kill MCMV-infected cells. IPCs and DCs lacking TLR9 or MyD88, an associated signaling molecule, failed to have this response. Unexpectedly, when IPC cells were experimentally depleted, resulting in a dramatic decrease in interferon levels, other cell types compensated for this deficiency by secreting cytokines that ensured an efficient activation of NK cells and substantial control of MCMV infection.

"In this study, we demonstrate that TLR9 recognizes MCMV in IPC and DC and that TLR9/MyD88 mediates a coordinate cytokine secretion by IPC, DC, and possibly other cell types, which is essential for rapid and efficient activation of antiviral-spe
'"/>

Contact: Heidi Hardman
hhardman@cell.com
617-397-2879
Cell Press
20-Jul-2004


Page: 1 2

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/30/2019)... ... September 30, 2019 , ... ... molecular manufacturing and other transformative technologies, announced the winners for the 2019 Foresight ... the other for Theory in nanotechnology/molecular manufacturing. , Established in 1993 and named ...
(Date:9/30/2019)... ... ... As human induced pluripotent stem cells (hiPSCs) move closer to becoming a ... the human heart, there is an increasing need for stable stem cell lines that ... and easily recorded. A study released today in STEM CELLS details the development of ...
(Date:9/30/2019)... Calif. (PRWEB) , ... September ... ... a leading think tank, research, and public interest organization focused on molecular ... Distinguished Student Prize. , The Award recognizes the College graduate or undergraduate ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... , ... October 02, 2019 , ... ... life sciences leadership firm that is enabling clinical program outsourcing success by cultivating ... by award-winning pharma and biotech veteran executive Brenda Reese, phaseUP™ brings clients deep, ...
(Date:10/3/2019)... BOSTON (PRWEB) , ... October 03, 2019 , ... Yesterday, ... 2-3, Asymmetrex founder and director, James L. Sherley, M.D., Ph.D., discussed important ... To an attendee audience including both developers and suppliers of clinical trials, in ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and ... company focused on the development of therapies to treat central nervous system ...
(Date:9/22/2019)... ... 20, 2019 , ... ZRT Laboratory is pleased ... serum . BDNF plays a vital role in protecting existing neurons in the ... neurons in the brain involved in learning, memory, and higher thinking. Low serum ...
Breaking Biology Technology:
Cached News: